Banerjee Subhashis sold $5K of ARTV
Banerjee Subhashis (Chief Medical Officer) sold 429 shares of Artiva Biotherapeutics, Inc. (ARTV) at $12.00 on 2026-08-18 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The transaction is a routine insider sale with limited market impact.
Market read
Low relevance; typical insider transaction with minimal price effect.
What to watch
Potential upcoming clinical data releases could change relevance of insider activity.
Background
Artiva Biotherapeutics filed a Form 4 reporting a $5K sale by its CMO under a pre‑arranged 10b5‑1 plan.
Ticker impact
Form 4 disclosed Chief Medical Officer Banerjee Subhashis sold 429 shares for $5,148 via a 10b5-1 plan.
minimal impact, price likely unchanged
Sale size is small relative to total holdings and market cap; typical for 10b5-1 plans.
Market effects
None; biotech sector not affected by a small insider transaction.
None; transaction is company‑specific.
None
Counterpoint
Even small insider sales can signal concerns; monitor upcoming disclosures.
Key entities
- CompanyArtiva Biotherapeutics, Inc.
Biotech firm developing therapies.
- ExecutiveBanerjee Subhashis
Chief Medical Officer of Artiva.